Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period

PLoS ONE

Volumn 12, Issue 11, 2017, Pages

  Abdin, Edimansyah ^a   Chong, Siow Ann ^a   Vaingankar, Janhavi Ajit ^a   Peh, Chao Xu ^a   Poon, Lye Yin ^a   Rao, Sujatha ^a   Verma, Swapna ^a   Subramaniam, Mythily ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DELUSION; DETERIORATION; EARLY PSYCHOSIS INTERVENTION PROGRAM; EARLY RESPONSE TRAJECTORY; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; FUNCTIONING TRAJECTORY; GENDER; GLOBAL ASSESSMENT OF FUNCTIONING; GROWTH CURVE; HEALTH PROGRAM; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MODERATELY STABLE FUNCTIONING TRAJECTORY; NO RESPONSE TRAJECTORY; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PSYCHOSIS; RELAPSE TRAJECTORY; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM; SOCIAL STATUS; STABLE TRAJECTORY; UNEMPLOYMENT; PSYCHOLOGY; SINGAPORE; YOUNG ADULT;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; SINGAPORE; YOUNG ADULT;

EID: 85033361169     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0187141     Document Type: Article

References (33)

1. Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004; 363(9426):2063–72. https://doi.org/10.1016/ S0140-6736(04)16458-1 PMID: 15207959.
2. Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ. 2013; 346:f185. https://doi.org/10.1136/bmj.f185PMID: 23335473; PubMed Central PMCID: PMCPMC3548617.
3. Verma S, Subramaniam M, Abdin E, Poon LY, Chong SA. Symptomatic and functional remission in patients with first-episode psychosis. Acta Psychiatr Scand. 2012; 126(4):282–9. https://doi.org/10.1111/j.1600-0447.2012.01883.x PMID: 22616617.
4. Verma S, Poon LY, Lee H, Rao S, Chong SA. Evolution of early psychosis intervention services in Singapore. East Asian Arch Psychiatry. 2012; 22(3):114–7. PMID: 23019285.
5. Chang WC, Kwong VW, Chan GH, Jim OT, Lau ES, Hui CL, et al. Prediction of functional remission in first-episode psychosis: 12-month follow-up of the randomized-controlled trial on extended early intervention in Hong Kong. Schizophr Res. 2016; 173(1–2):79–83. https://doi.org/10.1016/j.schres.2016.03. 016 PMID: 27017490.
6. Alvarez-Jimenez M, Gleeson JF, Henry LP, Harrigan SM, Harris MG, Killackey E, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med. 2012; 42(3):595–606. https://doi.org/10.1017/ S0033291711001504 PMID: 21854682.
7. Austin SF, Mors O, Secher RG, Hjorthoj CR, Albert N, Bertelsen M, et al. Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr Res. 2013; 150(1):163–8. https://doi.org/10.1016/j.schres.2013.07.031 PMID: 23932664.
8. Albert N, Bertelsen M, Thorup A, Petersen L, Jeppesen P, Le Quack P, et al. Predictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res. 2011; 125(2–3):257–66. https://doi.org/10.1016/j.schres.2010.10.013 PMID: 21056926.
9. Austin SF, Mors O, Budtz-Jorgensen E, Secher RG, Hjorthoj CR, Bertelsen M, et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort. Schizophr Res. 2015; 168(1–2):84–91. https://doi.org/10.1016/j.schres.2015.07.021PMID: 26265299.
10. Levine SZ, Rabinowitz J. Trajectories and antecedents of treatment response over time in early-episode psychosis. Schizophr Bull. 2010; 36(3):624–32. https://doi.org/10.1093/schbul/sbn120 PMID: 18849294; PubMed Central PMCID: PMCPMC2879688.
11. Levine SZ, Lurie I, Kohn R, Levav I. Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades. Schizophr Res. 2011; 126(1–3):184–91. https://doi.org/10.1016/j.schres.2010.10.026 PMID: 21093220.
12. Schennach R, Meyer S, Seemuller F, Jager M, Schmauss M, Laux G, et al. Response trajectories in "real-world" naturalistically treated schizophrenia patients. Schizophr Res. 2012; 139(1–3):218–24. https://doi.org/10.1016/j.schres.2012.05.004 PMID: 22658528.
13. Case M, Stauffer VL, Ascher-Svanum H, Conley R, Kapur S, Kane JM, et al. The heterogeneity of antipsychotic response in the treatment of schizophrenia. Psychol Med. 2011; 41(6):1291–300. https://doi.org/10.1017/S0033291710001893 PMID: 20925971; PubMed Central PMCID: PMCPMC3080711.
14. Muthen L, Muthen B. Mplus User’s Guide. Muthen & Muthen. 2015.
15. Hodgekins J, Birchwood M, Christopher R, Marshall M, Coker S, Everard L, et al. Investigating trajectories of social recovery in individuals with first-episode psychosis: a latent class growth analysis. Br J Psychiatry. 2015; 207(6):536–43. https://doi.org/10.1192/bjp.bp.114.153486 PMID: 26294371; PubMed Central PMCID: PMCPMC4664858.
16. Gee B, Hodgekins J, Fowler D, Marshall M, Everard L, Lester H, et al. The course of negative symptom in first episode psychosis and the relationship with social recovery. Schizophr Res. 2016; 174(1–3):165–71. https://doi.org/10.1016/j.schres.2016.04.017 PMID: 27131912.
17. Potkin S, Agid O, Siu C, Watsky E, Vanderburg D, Remington G. Placebo response trajectories in short-term and long-term antipsychotic trials in schizophrenia. Schizophr Res. 2011; 132(2–3):108–13. https://doi.org/10.1016/j.schres.2011.07.028 PMID: 21873032.
18. Levine SZ, Rabinowitz J, Case M, Ascher-Svanum H. Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study. J Clin Psychopharmacol. 2010; 30 (4):446–9. https://doi.org/10.1097/JCP.0b013e3181e68e80 PMID: 20631562.
19. Levine SZ, Rabinowitz J, Faries D, Lawson AH, Ascher-Svanum H. Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial. Schizophr Res. 2012; 137(1–3):141–6. https://doi.org/10.1016/j.schres.2012.01. 014 PMID: 22316567.
20. Pelayo-Teran JM, Diaz FJ, Perez-Iglesias R, Suarez-Pinilla P, Tabares-Seisdedos R, de Leon J, et al. Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis. Psychol Med. 2014; 44(1):37–50. https://doi.org/10.1017/ S0033291713000330 PMID: 23461899.
21. Department of Statistics. Yearbook of Statistics Singapore, 2016. Department of Statistics, Ministry of Trade & Industry, Singapore. 2014.
22. Verma S, Poon LY, Subramaniam M, Abdin E, Chong SA. The Singapore Early Psychosis Intervention Programme (EPIP): A programme evaluation. Asian J Psychiatr. 2012; 5(1):63–7. https://doi.org/10.1016/j.ajp.2012.02.001 PMID: 26878951.
23. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13(2):261–76. PMID: 3616518.
24. Piersma HL, Boes JL. The GAF and psychiatric outcome: a descriptive report. Community Ment Health J. 1997; 33(1):35–41. PMID: 9061261.
25. Nagin D. Group-based Modelling of Development: Harvard University Press; 2005.
26. Verma SK, Subramaniam M, Chong SA, Kua EH. Substance abuse in schizophrenia. A Singapore perspective. Soc Psychiatry Psychiatr Epidemiol. 2002; 37(7):326–8. https://doi.org/10.1007/s00127-002-0553-8 PMID: 12111024.
27. Rabinowitz J, Levine SZ, Haim R, Hafner H. The course of schizophrenia: progressive deterioration, amelioration or both? Schizophr Res. 2007; 91(1–3):254–8. https://doi.org/10.1016/j.schres.2006.12. 013 PMID: 17293084.
28. Pang S, Subramaniam M, Abdin E, Poon LY, Chong SA, Verma S. Gender differences in patients with first-episode psychosis in the Singapore Early Psychosis Intervention Programme. Early Interv Psychiatry. 2016; 10(6):528–34. https://doi.org/10.1111/eip.12208 PMID: 25601015.
29. Thorup A, Albert N, Bertelsen M, Petersen L, Jeppesen P, Le Quack P, et al. Gender differences in first-episode psychosis at 5-year follow-up—two different courses of disease? Results from the OPUS study at 5-year follow-up. Eur Psychiatry. 2014; 29(1):44–51. https://doi.org/10.1016/j.eurpsy.2012.11.005PMID: 23394824.
30. Chang WC, Tang JY, Hui CL, Chiu CP, Lam MM, Wong GH, et al. Gender differences in patients presenting with first-episode psychosis in Hong Kong: a three-year follow up study. Aust N Z J Psychiatry. 2011; 45(3):199–205. https://doi.org/10.3109/00048674.2010.547841 PMID: 21261552.
31. Cechnicki A, Hanuszkiewicz I, Polczyk R, Bielanska A. Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia. Med Sci Monit. 2011; 17(5):CR277–83. https://doi.org/10.12659/MSM.881768 PMID: 21525810; PubMed Central PMCID: PMCPMC3539595.
32. Silverstein SM, Bellack AS. A scientific agenda for the concept of recovery as it applies to schizophrenia. Clin Psychol Rev. 2008; 28(7):1108–24. https://doi.org/10.1016/j.cpr.2008.03.004 PMID: 18420322.
33. Melchior H, Schulz H, Kriston L, Hergert A, Hofreuter-Gatgens K, Bergelt C, et al. Symptom change trajectories during inpatient psychotherapy in routine care and their associations with long-term outcomes. Psychiatry Res. 2016; 238:228–35. https://doi.org/10.1016/j.psychres.2016.02.046 PMID: 27086238.